In 2018 IFCAH funded projects on Congenital Adrenal Hyperplasia for an amount of 350000€. Following IFCAH’s call for projects, 14 letters of intent have been received. Among them, 5 projects have been pre-selected for being reviewed and auditioned by the scientific committee the 18 of June 2018.
Pr Michel Polak (president of IFCAH’s scientific committee) announced the selected projects at the 57th International Meeting of ESPE in Athens. Selected projects are listed hereafter:
“Pathophysiology and therapeutic challenges of Congenital Adrenal Hyperplasia”, Dr. Gerard Babot, IFCAH and AFM Funding: 150 000 € (AFM Partnership)
“The epidemiology of congenital adrenal hyperplasia: a nationwide study.”, Dr. Claus Gravholt, IFCAH funding: 100 000 €
“In vivo characterisation of ACTH receptor antagonists.”, Dr. Li Chan (UK), IFCAH funding: 100 000 €
Funded projects summaries are available online on our IFCAH website.